Robert Apple

Currently holds a position at Antares Pharma Inc

Position	Company	Period
President, Chief Executive Officer, Director	Antares Pharma Inc	March 4, 2016 -
President, Chief Executive Officer	Antares Pharma Inc	Jan. 24, 2016 - March 4, 2016
Chief Operating Officer, Executive Vice President, President - Parenteral Products Division	Antares Pharma Inc	Nov. 17, 2014 - Jan. 24, 2016
Chief Financial Officer, Chief Operating Officer, Executive Vice President, President - Parenteral Products Division	Antares Pharma Inc	Sept. 15, 2014 - Nov. 17, 2014
Chief Financial Officer, Executive Vice President, President - Parenteral Products Division	Antares Pharma Inc	July 8, 2009 - Sept. 15, 2014

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2021-02-19	2021-02-18	Antares Pharma Inc (ATRS)	PlS Planned sale	609 +31.9% 442.56 US$4,339,532	609 +31.9%	442.56	US$4,339,532
2021-02-19	2021-02-18	Antares Pharma Inc (ATRS)	PlS Planned sale	43,836 +35.0% 381.23 US$2,158,333	43,836 +35.0%	381.23	US$2,158,333
2021-02-19	2021-02-18	Antares Pharma Inc (ATRS)	PlS Planned sale	48,277 +42.5% 241.44 US$2,961,728	48,277 +42.5%	241.44	US$2,961,728
2021-02-19	2021-02-17	Antares Pharma Inc (ATRS)	PlS Planned sale	5,519 -0.2% 4.75 US$26,215	5,519 -0.2%	4.75	US$26,215
2021-02-10	2021-02-10	Antares Pharma Inc (ATRS)	PlS Planned sale	7,278 -0.3% 4.75 US$34,570	7,278 -0.3%	4.75	US$34,570
2021-02-10	2021-02-09	Antares Pharma Inc (ATRS)	PlS Planned sale	49,129 -2.1% 4.75 US$233,363	49,129 -2.1%	4.75	US$233,363
2021-02-10	2021-02-08	Antares Pharma Inc (ATRS)	PlS Planned sale	33,574 -1.4% 4.75 US$159,476	33,574 -1.4%	4.75	US$159,476